Glucagon-like peptide-1 receptor agonist use is associated with reduced risk of out-of-hospital cardiac arrest in women with type 2 diabetes: A nationwide nested case-control study.
使用胰高血糖素樣肽-1受體激動劑與降低2型糖尿病女性院外心臟驟停風險相關：一項全國性嵌套病例對照研究。
Resusc Plus 2024-11-21
Effects of GLP-1 Agonists on mortality and arrhythmias in patients with Type II diabetes.
GLP-1激動劑對2型糖尿病患者死亡率和心律失常的影響。
Int J Cardiol Heart Vasc 2023-05-31
Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study.
糖尿病成人中胰高血糖素樣肽-1受體激動劑與房顫風險：一項真實世界研究。
J Gen Intern Med 2024-01-23
Relationship between Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Disease in Chronic Respiratory Disease and Diabetes.
GLP-1受體激動劑與慢性呼吸道疾病和糖尿病心血管疾病的關係。
Biomedicines 2024-03-30
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries.
瑞典心臟衰竭和瑞典全國糖尿病登記資料庫中胰高血糖素樣肽-1 受體激動劑的使用及其與心臟衰竭和2型糖尿病結果的關聯。
Eur Heart J Cardiovasc Pharmacother 2024-04-17
Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists.
接受 GLP-1 受體激動劑治療的第二型糖尿病患者的真實世界性別差異。
Diabetes Res Clin Pract 2024-05-05
Glucagon-like-peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study.
糖尿病患者中胰高血糖素樣肽-1受體激動劑與二肽基胺基肽酶-4抑制劑，以及心血管結果之比較，與達到的血糖控制相關的丹麥全國性研究。
J Diabetes 2024-05-18
Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials.
糖尿病患者和非糖尿病患者中胰高血糖素樣肽-1受體激動劑與主要不良心血管事件：隨機對照試驗的荟萃分析。
Clin Cardiol 2024-07-02
Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes.
糖尿病患者中胰高血糖素樣肽-1受體激動劑與13種與肥胖相關的癌症。
JAMA Netw Open 2024-07-05
Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.
胰高血糖素樣肽-1 受體激動劑改善有無心衰竭的 2 型糖尿病患者的預後。
Int J Cardiol 2024-10-11